Associate professor Ragnhild Eskeland at CanCell and the University of Oslo explains that it is a gene-editing tool which is based on the self-defense used by bacteria. CRISPR/Cas9 is diligently used by researchers that wants to unravel how genes are regulated in cancers like breast cancer and prostate cancer she says. In her article she explains that the gene-editing tool already has contributed to the development of treatments against diseases that earlier on could not be cured.
At CanCell we are collaborating with other cancer researchers and use CRISPR/Cas9 to develop new cancer treatments. Our goal is to reprogram cancer cells to become benign cells Eskeland says.
Read her article here (Norwegian) to discover how the bacterial self-defense gives us the keys to understand the processes of cancer and to read more about CRISPR.